GS
Gajanan Subhash Gondafale
About Gajanan Subhash Gondafale
Data last updated:
Gajanan Subhash Gondafale is a Director at Turret Pharma Private Limited (since 2013). The company operates in Pharma. Turret Pharma Private Limited reported revenue of ₹5.84 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Turret Pharma Private Limited U24233MH2013PTC250141 | Director | 16 Nov 2013 | 2013 | ₹5.84 Cr (FY 2024) | Active |
Board colleagues of Gajanan Subhash Gondafale
| Name | DIN | Company | Designation |
|---|---|---|---|
| Santosh Subhash Gondphale | 08196535 | Turret Pharma Private Limited | Director |
| Tanaji Purabhaji Jadhav | 06716997 | Turret Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gajanan Subhash Gondafale
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gajanan Subhash Gondafale
Gajanan Subhash Gondafale currently holds 1 directorship: Turret Pharma Private Limited (Director, since 16 Nov 2013, revenue ₹5.84 Cr (FY 2024)).
Gajanan Subhash Gondafale was first appointed on 16 Nov 2013 as Director at Turret Pharma Private Limited.
The current boards of Gajanan Subhash Gondafale's companies include Santosh Subhash Gondphale (Turret Pharma Private Limited), Tanaji Purabhaji Jadhav (Turret Pharma Private Limited).